Improve balance during dual tasking

Trial ID
NCT06615115
Official Title
Effects of an External and Combined Focus of Attention-Instructed Exercise Program on Postural Stability and Dual-Task Walking in Parkinson's Disease: A Randomized, Assessor-Blinded, Controlled Trial
Goal
Improve balance during dual tasking
Phase
NA
Status
RECRUITING
Sponsor
Bahçeşehir University
Study Type
INTERVENTIONAL
Enrollment
48 participants
Conditions
Parkinson Disease, Cognitive Deficit in Attention, Feedback, Psychological, Gait, Festinating
Interventions
Exercise

Plain-Language Summary

It aims to improve postural stability and walking while multitasking, the kinds of balance and dual-task problems that increase fall risk and cause festinating gait. The program uses guided exercises that teach an external and combined focus of attention, meaning people are cued to focus on movement outcomes or external targets instead of their body, which encourages more automatic motor control and steadier balance and gait under dual-task conditions. The trial is enrolling people aged 50 to 70 with mild to moderate Parkinson's, Hoehn and Yahr stage II or III, who walk independently but have balance issues, score 21,56 on the Berg Balance Scale and 24,30 on the MMSE, are in their medication-on period, and do not have freezing of gait, deep brain stimulators, dyskinesia, major neurological or sensory problems, or serious medical conditions.

Locations

  • Atafiz Tıp Merkezi, Istanbul, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Exercise. It aims to improve postural stability and walking while multitasking, the kinds of balance and dual-task problems that increase fall risk and cause festinating gait. The program uses guided exercises that teach an external and combined focus of attention, meaning people are cued to focus on movement outcomes or external targets instead of their body, which encourages more automatic motor control and steadier balance and gait under dual-task conditions. The trial is enrolling people aged 50 to 70 with mild to moderate Parkinson's, Hoehn and Yahr stage II or III, who walk independently but have balance issues, score 21,56 on the Berg Balance Scale and 24,30 on the MMSE, are in their medication-on period, and do not have freezing of gait, deep brain stimulators, dyskinesia, major neurological or sensory problems, or serious medical conditions.
Who can participate?
Participants must be between 50 Years and 70 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 4 months.

View on ClinicalTrials.gov